Search Within

Carl Ola Landgren

Formats
  1. Meeting Abstract (155)
  2. Journal Article (151)
  3. Review (14)
  4. Research Letter (7)
  5. Book Section (3)
  6. Correspondence (2)
  7. Guidelines (2)
  8. Conference Paper (1)
  9. Editorial (1)
Groups
  1. Center for Hematologic Malignancies (336)
  2. Department of Medicine (336)
  3. Hematologic Malignancies Research (336)
  4. Hematologic Malignancies, Division of (336)
  5. Myeloma (336)
  6. Survivorship Research (132)

More Groups

People
  1. Neha Korde (106)
  2. Sham Mailankody (91)
  3. Alexander Lesokhin (83)
  4. Malin Hultcrantz (81)
  5. Hani Hassoun (77)
  6. Sergio Giralt (73)

More People

Years
  1. 2023 (2)
  2. 2022 (4)
  3. 2021 (21)
  4. 2020 (52)
  5. 2019 (56)
  6. 2018 (51)

More Years

Publications
  1. Blood (102)
  2. Haematologica (25)
  3. Clinical Lymphoma, Myeloma and Leukemia (21)
  4. Leukemia and Lymphoma (16)
  5. Biology of Blood and Marrow Transplantation (13)
  6. Blood Cancer Journal (10)

More Publications

Publishers
  1. American Society of Hematology (109)
  2. Elsevier Inc. (45)
  3. Nature Publishing Group (29)
  4. Ferrata Storti Foundation (25)
  5. Taylor & Francis Group (17)
  6. American Association for Cancer Research (15)

More Publishers

Results (336)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Guidelines for acquisition, interpretation, and reporting of whole-body MRI in myeloma: Myeloma Response Assessment and Diagnosis System (MY-RADS)
    Guidelines

    Messiou, C.; Hillengass, J.; Delorme, S.; Lecouvet, F. E.; Moulopoulos, L. A.; Collins, D. J.; Blackledge, M. D.; Abildgaard, N.; Østergaard, B.; Schlemmer, H. P.; more...
    Radiology (2019)

    Fulltext@MSK | Save
  • Baseline identification of clonal V(D)J sequences for DNA-based minimal residual disease detection in multiple myeloma
    Journal Article

    Rustad, E. H.; Hultcrantz, M.; Yellapantula, V. D.; Akhlaghi, T.; Ho, C.; Arcila, M. E.; Roshal, M.; Patel, A.; Chen, D.; Devlin, S. M.; more...
    PLoS ONE (2019)

    Fulltext@MSK | Save
  • Establishment of immunoglobulin heavy (IGH) chain clonality testing by next-generation sequencing for routine characterization of B-cell and plasma cell neoplasms
    Journal Article

    Arcila, M. E.; Yu, W.; Syed, M.; Kim, H.; Maciag, L.; Yao, J.; Ho, C.; Petrova, K.; Moung, C.; Salazar, P.; more...
    Journal of Molecular Diagnostics (2019)

    Fulltext@MSK | Save
  • Molecular underpinnings of clinical disparity patterns in African American vs. Caucasian American multiple myeloma patients
    Journal Article

    Kazandjian, D.; Hill, E.; Hultcrantz, M.; Rustad, E. H.; Yellapantula, V.; Akhlaghi, T.; Korde, N.; Mailankody, S.; Dew, A.; Papaemmanuil, E.; more...
    Blood Cancer Journal (2019)

    Fulltext@MSK | Save
  • Significant nationwide variability in the costs and hospital mortality rates of autologous stem cell transplantation for multiple myeloma: An analysis of the Nationwide Inpatient Sample database
    Journal Article

    Liu, Y.; Han, H.; Shah, G.; Giralt, S.; Landgren, C. O.; He, J.; Lesokhin, A. M.
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Phase 1, multicenter, open-label study of single-agent bispecific antibody t-cell engager GBR 1342 in relapsed/refractory multiple myeloma
    Meeting Abstract

    Richter, J. R.; Landgren, C. O.; Kauh, J. S.; Back, J.; Salhi, Y.; Reddy, V.; Bayever, E.; Berdeja, J. G.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Molecular underpinnings of clinical disparity patterns in African American (AA) versus Caucasian American (CA) multiple myeloma (MM) patients
    Meeting Abstract

    Hill, E. M.; Kwok, M.; Yellapantula, V.; Hultcrantz, M.; Korde, N.; Mailankody, S.; Papaemmanuil, E.; Maric, I.; Kazandjian, D. G.; Landgren, O.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Weekly carfilzomib, lenalidomide, and dexamethasone (KRd) in relapsed or refractory multiple myeloma (RRMM): A phase 1b study
    Meeting Abstract

    Biran, N.; Di Capua Siegel, D. S.; Berdeja, J. G.; Raje, N. S.; Cornell, R. F.; Alsina, M.; Kovacsovics, T.; Fang, B.; Kimball, A.; Landgren, C. O.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Circulating immunologic markers and risk of multiple myeloma and its precursor disease: A nested case-control study
    Meeting Abstract

    Hofmann, J. N.; Landgren, O.; Katki, H.; Kemp, T.; Santo, L.; McShane, C.; Lan, Q.; Rothman, N.; Pinto, L.; Pfeiffer, R.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Nrf2-mediated oxidative stress response is altered during acquired resistance to the proteasome inhibitor, oprozomib, in multiple myeloma
    Meeting Abstract

    Gaikwad, S. M.; Zingone, A.; Michalowski, A.; Najera, S.; Quintanilla-Artega, A.; Gorjifard, S.; Simmons, J.; Watson, N.; Landgren, O.; Huang, J.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save